A breast cancer vaccine could be closer to reality, according to Cleveland Clinic, as its researchers have announced some encouraging results. Researchers and doctors weigh in.

An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, new research suggests.

An experimental vaccine teaching patients’ immune systems to identify and attack cancer cells could help women diagnosed with triple-negative breast cancer.

A groundbreaking treatment has been announced for women with an extremely aggressive form of breast cancer. Siteman Cancer Center just released the results of a clinical trial showing a new vaccine that is preventing cancer from returning.

A trial of the vaccine showed it to be "well-tolerated" and to stimulate the immune system. The post New vaccine shows promise in treating aggresive form of breast cancer appeared first on Talker.

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors. Conducted at Washington University School of Medicine in St.

New research suggests an experimental vaccine could provide new hope for women diagnosed with an aggressive, hard-to-treat form of breast cancer. This vaccine is effective against triple-negative breast cancer,

The Cleveland Clinic is seeing positive results in their preventive cancer vaccine study that could prevent the most aggressive form of breast cancer.

Researchers say the results mark the first time a vaccine - known as a neoantigen DNA vaccine - has shown such positive results in a clinical trial.